15h
The Print on MSNFat-busting drug Mounjaro launched in India. Here’s how much it will costUS pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...
Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...
Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results